Shimadzu (Kyoto, Japan), an international provider of analytical instrumentation, has opened a branch office in Stockholm (Sweden).
Thermo Fisher Scientific (MA, USA) and Cedars-Sinai (CA, USA) announce a collaboration that promises to develop robust, sensitive and reliable LC—MS based workflows for clinical research applications.
In this interview, John Kadavil (US FDA; MA, USA) shares his thoughts on the draft ICH M10 guidance for bioanalytical method validation, indicating how this will change the bioanalytical regulatory landscape.
In this interview, Eric Woolf (Merck; PA, USA) provides an overview of the draft ICH M10 guidance for bioanalytical method validation, indicating why there is a need for new guidance despite many BMV guidance currently being available.
Verify Life Science LLC (CA, USA), health and life sciences company under Alphabet, recently announced its partnerships with four major pharmaceutical companies to allow them to move into the clinical trial market.
Global leaders in life sciences and nonclinical drug development, Envigo (Huntingdon, UK) and LabCorp (NC, USA), have signed an innovative agreement in a bid to expand nonclinical drug development capabilities and create an independent research models provider.
Charles River Laboratories have signed an agreement to acquire Citoxlab for $510 million in a deal that aims to expand their global scale and scientific service portfolio.
Bristol-Myers Squibb (NY, USA) have announced that they will be acquiring Celgene (NJ, USA) this year for a cost of $74 billion.
Webinar available to view on demand. Exploring the challenges a lack of industry standardization presents for CRO project managers and scientists as well as biopharma and biotech companies.